Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2
Oncology Reports - Greece
doi 10.3892/or.2018.6735
Full Text
Open PDFAbstract
Available in full text
Date
September 26, 2018
Authors
Publisher
Spandidos Publications